April 3, 2022

Junshi Biosciences Announces FDA Approval of Investigational New Drug Application for Anti-CD112R Monoclonal Antibody for Treatment of Advanced Solid Tumors

SHANGHAI, China, April 03, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug

Read More

Smooth traffic on all major highways as of midday

KUALA LUMPUR, April 3 (Bernama) – Traffic flow on all major highways was reported to be smooth as of 1 pm today.A Malaysian Highway Authority (LLM) spokesman said traffic flow to the capital and other places was also smooth, except from Permatang Pauh …

Read More